Congress trades in Abbott Laboratories (ABT)
12 of the members we track disclosed 25 purchases of ABT between 2022-04-19 and 2026-06-16, and 28 sales. Here is what the stock did afterwards.
Every purchase is measured over the three months after the transaction date, against XLV — the ETF standing in for Healthcare & Pharma — over exactly the same dates. The second figure is the one that carries information: the first mostly reflects what the sector did. How ABT was classified.
How these buys are tagged
6 of these purchases were made by a member whose own committee oversees Healthcare & Pharma. 11 are marked Cluster: A buy is marked Cluster when at least one other tracked member of Congress bought the same stock within 30 days of it, regardless of committee membership.
| Buys | Number | Return after 3 months | vs. sector | Beat their sector |
|---|---|---|---|---|
| All buys | 25 | +2.1% | +0.9% | 64% |
| Notable (committee-flagged) | 6 | +5.7% | +2.2% | 67% |
| Unaligned (no committee overlap) | 19 | +1.0% | +0.4% | 63% |
| Cluster, excl. mega-caps | 11 | +2.9% | -1.2% | 55% |
| Not clustered, excl. mega-caps | 14 | +1.5% | +2.5% | 71% |
Who bought the most
- Josh Gottheimer — 5 buys
- Richard McCormick — 4 buys
- Thomas H. Kean, Jr. — 4 buys
- Gilbert Ray Cisneros, Jr. — 2 buys
- Markwayne Mullin — 2 buys
Every disclosed purchase
| Member | Bought disclosed |
Signal | Price | 1W | 1M | 3M | vs sector |
|---|---|---|---|---|---|---|---|
| Gilbert Ray Cisneros, Jr. | 2026-06-16 2026-07-02 |
Unaligned Cluster | $90.62 | -0.1% | +9.1% | +12.6% | +3.0% |
| Richard McCormick | 2026-06-12 2026-07-09 |
Unaligned Cluster | $88.18 | +0.3% | +6.5% | +15.6% | +8.1% |
| Richard McCormick | 2026-03-19 2026-04-07 |
Unaligned | $107.19 | -2.4% | -9.7% | -17.5% | -19.4% |
| Thomas H. Kean, Jr. | 2026-01-29 2026-02-19 |
Notable | $106.09 | +2.8% | +9.7% | -14.4% | -9.3% |
| Gilbert Ray Cisneros, Jr. | 2025-11-18 2025-12-15 |
Unaligned Cluster | $130.00 | -1.5% | -3.8% | -13.6% | -16.8% |
| Richard McCormick | 2025-11-05 2025-12-09 |
Unaligned Cluster | $124.54 | +3.4% | +0.4% | -13.1% | -20.2% |
| Rick Larsen | 2025-10-06 2025-10-16 |
Unaligned Cluster | $133.74 | -1.8% | -6.9% | -5.5% | -13.0% |
| Thomas H. Kean, Jr. | 2025-07-21 2025-08-20 |
Notable Cluster | $124.42 | +1.6% | +6.4% | +4.1% | -6.4% |
| Lisa C. McClain | 2025-06-24 2025-08-13 |
Unaligned Cluster | $138.08 | -1.3% | -9.0% | -1.6% | -3.9% |
| Byron Donalds | 2025-03-20 2025-04-14 |
Unaligned | $126.78 | +3.6% | +3.3% | +4.4% | +13.8% |
| Josh Gottheimer | 2025-02-13 2025-03-06 |
Unaligned | $131.79 | +1.0% | -3.9% | +1.2% | +12.1% |
| Josh Gottheimer | 2025-01-29 2025-02-10 |
Unaligned | $127.86 | +3.3% | +7.9% | +2.3% | +5.8% |
| Josh Gottheimer | 2025-01-28 2025-02-10 |
Unaligned | $127.39 | +1.3% | +6.7% | +2.4% | +7.4% |
| Thomas H. Kean, Jr. | 2024-12-16 2025-01-22 |
Notable | $112.62 | +1.5% | -1.3% | +13.3% | +8.0% |
| Julia Letlow | 2024-10-23 2026-01-13 |
Notable | $117.01 | -2.2% | +0.6% | +0.7% | +6.1% |
| Josh Gottheimer | 2024-08-19 2024-09-11 |
Unaligned Cluster | $111.90 | +0.7% | +2.7% | +4.9% | +12.6% |
| Josh Gottheimer | 2024-07-29 2024-08-15 |
Unaligned Cluster | $104.77 | +3.7% | +7.8% | +8.9% | +9.7% |
| Thomas H. Kean, Jr. | 2024-07-23 2024-08-19 |
Notable Cluster | $103.92 | +1.3% | +7.9% | +11.7% | +10.1% |
| Jared Moskowitz | 2024-07-05 2024-08-19 |
Unaligned Cluster | $104.02 | +0.2% | +7.0% | +8.3% | +3.3% |
| John James | 2023-11-10 2024-09-02 |
Notable | $93.97 | +5.9% | +11.2% | +19.0% | +4.9% |
| Markwayne Mullin | 2023-10-03 2023-11-01 |
Unaligned | $95.79 | +1.8% | +0.2% | +14.7% | +5.8% |
| Markwayne Mullin | 2023-09-13 2023-10-12 |
Unaligned | $102.69 | -2.3% | -11.5% | +4.4% | +2.1% |
| Richard McCormick | 2023-03-15 2025-09-17 |
Unaligned | $97.80 | -1.0% | +6.3% | +5.6% | +2.5% |
| Robert J. Wittman | 2022-07-15 2022-08-10 |
Unaligned | $108.82 | +0.3% | +2.4% | -7.3% | -2.4% |
| Robert J. Wittman | 2022-04-19 2022-05-13 |
Unaligned | $119.98 | -2.5% | -6.3% | -8.4% | -2.0% |
Prices are the closing price on the transaction date, not what was paid: filings never disclose an execution price. Blank figures mean the window has not elapsed yet. Sales are not scored — a sale closes a position rather than opening one — so the 28 disclosed sales of ABT are not in this table.
Download the data behind this page, or read how every figure is calculated. Trades in ABT are a small part of the full rankings, which score each member across everything they bought.
Data last updated .